NKTX 8-K 2026-11-05

Nkarta, Inc. (NKTX) 8-K dated 2026-11-05 — accession 0001787400-26-000020.

Nkarta, Inc. (NKTX) is a biotechnology company listed on NASDAQ.

Nkarta, Inc. filed a 8-K on 2026-11-05. Accession 0001787400-26-000020.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported NKTX revenue for 2025-12-31 was $0. Net income was -$104.1M. NKTX currently screens at market cap $188.9M.

Not investment advice. The NKTX SEC hub lists recent forms. The stock page is the research view.